SHEA letter to FDA regarding fecal microbiota for transplantation (FMT) guidance
- Details
- Written by SHEA
- Wednesday, 26 March 2014
SHEA submitted comments to FDA on its Guidance for industry regarding enforcement policy for use of FMT to treat Clostridium difficile infection not responsive to standard therapies.